Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Huang
M E
ME
Shanghai Institute of Hematology, Shanghai Second Medical University, People's Republic of China.
Ye
Y C
YC
Chen
S R
SR
Chai
J R
JR
Lu
J X
JX
Zhao
L
L
Gu
L J
LJ
Wang
Z Y
ZY
D000293:Adolescent; D000328:Adult; D000368:Aged; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced / Q000453:epidemiology; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction; D013237:Stereoisomerism; D014212:Tretinoin / Q000009:adverse effects / Q000627:therapeutic use*; D014410:Tumor Stem Cell Assay
D014212:Tretinoin